December 16, 2014

“U.S. Patent Office Revises Guidelines After Drugmakers Complain,” The Wall Street Journal, December 16, 2014

Wall Street Journal
View Link

The guidelines were designed to help examiners evaluate patents related to natural products, but the effort caused a ruckus because the agency took a stance that industry complained was too restrictive and was prompting examiners to analyze whether an invention was eligible to be patented.

“The guidance went beyond what the Supreme Court was saying in those cases,” says Leanne Rakers, an attorney at the Harness Dickey law firm, who specializes in intellectual property issues.

Read full article.